Your browser doesn't support javascript.
loading
Autoantibodies against ß1-adrenergic receptor: response to induction therapy with bortezomib-containing regimens for multiple myeloma patients.
Gao, Wen; Guo, Wen-Jia; Hou, Dong-Yan; Yang, Guang-Zhong; Wu, Yin; Li, Yan-Chen; Leng, Yun; Tang, Yu; Xu, Lin; Liu, Jia-Mei; Wang, Hua; Wang, Xin; Zhang, Juan; Zhao, Wen-Shu; Chen, Wen-Ming; Zhang, Lin.
Afiliação
  • Gao W; a Department of Hematology , Myeloma Research Center of Beijing, Beijing Chao-Yang Hospital, Capital Medical University , Beijing , China.
  • Guo WJ; b Department of Cardiology , Heart Failure Center, Capital Medical University, Beijing Chao-Yang Hospital , Beijing , China.
  • Hou DY; c Beijing Key Laboratory of Metabolic Disorders Related Cardiovascular Diseases , Beijing , China.
  • Yang GZ; b Department of Cardiology , Heart Failure Center, Capital Medical University, Beijing Chao-Yang Hospital , Beijing , China.
  • Wu Y; c Beijing Key Laboratory of Metabolic Disorders Related Cardiovascular Diseases , Beijing , China.
  • Li YC; a Department of Hematology , Myeloma Research Center of Beijing, Beijing Chao-Yang Hospital, Capital Medical University , Beijing , China.
  • Leng Y; a Department of Hematology , Myeloma Research Center of Beijing, Beijing Chao-Yang Hospital, Capital Medical University , Beijing , China.
  • Tang Y; a Department of Hematology , Myeloma Research Center of Beijing, Beijing Chao-Yang Hospital, Capital Medical University , Beijing , China.
  • Xu L; a Department of Hematology , Myeloma Research Center of Beijing, Beijing Chao-Yang Hospital, Capital Medical University , Beijing , China.
  • Liu JM; b Department of Cardiology , Heart Failure Center, Capital Medical University, Beijing Chao-Yang Hospital , Beijing , China.
  • Wang H; c Beijing Key Laboratory of Metabolic Disorders Related Cardiovascular Diseases , Beijing , China.
  • Wang X; b Department of Cardiology , Heart Failure Center, Capital Medical University, Beijing Chao-Yang Hospital , Beijing , China.
  • Zhang J; c Beijing Key Laboratory of Metabolic Disorders Related Cardiovascular Diseases , Beijing , China.
  • Zhao WS; b Department of Cardiology , Heart Failure Center, Capital Medical University, Beijing Chao-Yang Hospital , Beijing , China.
  • Chen WM; c Beijing Key Laboratory of Metabolic Disorders Related Cardiovascular Diseases , Beijing , China.
  • Zhang L; b Department of Cardiology , Heart Failure Center, Capital Medical University, Beijing Chao-Yang Hospital , Beijing , China.
Leuk Lymphoma ; 59(3): 717-724, 2018 03.
Article em En | MEDLINE | ID: mdl-28679329
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores Adrenérgicos beta 1 / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores Adrenérgicos beta 1 / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos